Fig. 1.
Kaplan–Meier curves for progression-free survival A and overall survival B for patients receiving RT plus PD-1 inhibitors and lenvatinib
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.